The substantial weight loss and improved cardiometabolic health achieved by people given an exciting new drug to treat obesity is maintained if people continue to take the mediation.
Monoclonal antibody therapies continue to neutralise SARS-CoV-2 variants currently in circulation, according to laboratory findings from the BRC and the Francis Crick Institute.
A new PCR test that identifies women with womb cancer from a sample taken from the cervix or vagina has been developed by researchers from UCL and the University of Innsbruck.
An international team including UCL and UCLH researchers have set out a framework to improve the integrity and quality of research using healthcare data.
A study at UCLH has found a combination treatment of immunotherapy with an experimental drug may reverse a cancer’s resistance to immunotherapy – making the cancer sensitive to treatment again.
Patients and the public are invited to an event on Saturday 24 September 2022 to learn about UCLH research in rheumatological conditions such as rheumatoid arthritis, lupus and gout.